Placeholder Banner

EWIB Partners with BIO to Promote Gender Diversity on Corporate Boards

Executive Women in Bio (EWIB) partners with BIO to promote gender diversity on corporate boards. The new partnership will help change the landscape of life science boardrooms by expanding executive women's resources and visibility.

June 27, 2019
Media Contact
Theresa Brady

NEW YORK – June 25, 2019 – Executive Women in Bio (EWIB), a committee comprised of senior leaders in the life sciences and biopharma operating within the national non-profit organization, Women In Bio (WIB), is pleased to announce a new partnership with the Biotechnology Innovation Organization (BIO). Through this partnership, senior women executives who complete EWIB’s Boardroom Ready program can elect to be listed on BIO Boardlist, a searchable directory of eligible executives in which members can recommend peers and companies can find board candidates that best fit their business needs.

With less than 15 percent of life science company board positions filled by women, increasing equity in consideration for these leadership positions will take a change in thinking across the industry. Motivated by both the moral obligation to give all eligible candidates equal opportunity to advance up the corporate ladder, as well as the growing body of research indicating that diverse boards tend to generate returns above the industry average, EWIB and BIO have developed programs and taken steps to counteract women’s underrepresentation on executive boards.

“Executive Women In Bio established the Boardroom Ready program to help experienced female leadership overcome the hurdles to obtaining a corporate board seat,” said Carolyn Brougham, executive liaison at WIB. ”Adding the program alumnae to the BIO Boardlist furthers the mission of EWIB and Boardroom Ready by expanding the resources, network, and opportunities available for these outstanding life science executives.”

Each year, EWIB’s Boardroom Ready program selects 20 top biotech and pharmaceutical executive women to participate in an intensive board competency-building curriculum to refine each candidate’s understanding of the responsibilities related to serving on both public and private boards. A key benefit of this program is leveraging the extensive network of WIB, experienced board mentors, and supporters throughout the life sciences. To date, program participants have been appointed to 32 board positions.   

“It makes more than just common sense, but also business sense, that governing boards of biopharmaceutical companies reflect the diversity seen within the ranks of their scientists, entrepreneurs, investors, and patients.” said Helen Torley, M.B. Ch.B., M.R.C.P, President, CEO and member of the Board of Directors of Halozyme Therapeutics and chair of BIO’s Workforce Development, Diversity & Inclusion (WDDI) Committee. “We have launched the BIO Boardlist, to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards. We are excited to partner with EWIB to populate this database and showcase the wealth of talent that lies within senior leadership.”

BIO Boardlist is a part of The Right Mix Matters initiative, which recently launched to advance a more globally competitive industry through resources and tools for BIO members and the larger biotech community. This is just one of many ways BIO is working to promote diversity and inclusion in life sciences hiring practices and expand representation on biotech company boards, in c-suites and in functional leadership positions.

Please visit The Right Mix Matters or Boardroom Ready to learn more.

About EWIB

Executive Women In Bio (EWIB) is a committee comprised of senior leaders in biopharma and the life sciences operating within the membership-based, national non-profit organization, Women In Bio (WIB). EWIB champions for greater diversity and is committed to supporting female leadership through professional development programs, including Boardroom Ready. EWIB strives to be a foundational resource for women in executive roles, by fostering achievement and empowering women to be the best leaders and influencers they can be through formal education, training, and structured networking. EWIB offers a competitive, intensive board competency-building curriculum held annually at George Washington University to refine skills and to increase preparedness for the responsibilities related to serving on both public and private boards.


Discover More
Washington, DC (December 2, 2020) - Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement regarding Nasdaq's filing with the Securities and Exchange Commission…
BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement in advance of a congressional subcommittee hearing in the House Committee on Energy and Commerce on racial and ethnic disparities in Covid-19:   “The…
Philadelphia, PA (June 4, 2019) – The Biotechnology Innovation Organization (BIO) released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives” today at the 2019 BIO International…